Nurix Therapeutics, Inc.
NRIX
$15.96
-$0.32-1.97%
NASDAQ
| 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 540.73M | 592.94M | 428.83M | 485.78M | 549.68M |
| Total Receivables | 2.40M | 1.50M | 1.70M | 20.70M | 2.10M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 11.26M | 12.38M | 10.07M | 8.85M | 11.92M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 554.39M | 606.82M | 440.60M | 515.33M | 563.70M |
|
|
|||||
| Total Current Assets | 554.39M | 606.82M | 440.60M | 515.33M | 563.70M |
| Net Property, Plant & Equipment | 73.35M | 73.01M | 73.53M | 68.99M | 44.81M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 8.38M | 8.31M | 8.34M | 7.24M | 6.53M |
| Total Assets | 636.13M | 688.14M | 522.47M | 591.56M | 615.04M |
|
|
|||||
| Total Accounts Payable | 10.29M | 11.22M | 8.61M | 5.95M | 8.40M |
| Total Accrued Expenses | 56.99M | 51.70M | 41.30M | 35.05M | 40.34M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.20M | 2.82M | 3.79M | 5.24M | 6.64M |
| Total Finance Division Other Current Liabilities | 21.72M | 20.74M | 28.66M | 29.37M | 34.61M |
| Total Other Current Liabilities | 21.72M | 20.74M | 28.66M | 29.37M | 34.61M |
| Total Current Liabilities | 92.20M | 86.47M | 82.35M | 75.61M | 89.99M |
|
|
|||||
| Total Current Liabilities | 92.20M | 86.47M | 82.35M | 75.61M | 89.99M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 55.45M | 52.91M | 52.70M | 46.70M | 19.98M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 7.59M | 10.01M | 15.18M | 21.64M | 24.15M |
| Total Liabilities | 155.24M | 149.39M | 150.22M | 143.95M | 134.13M |
|
|
|||||
| Common Stock & APIC | 1.57B | 1.54B | 1.30B | 1.29B | 1.28B |
| Retained Earnings | -1.09B | -1.00B | -925.01M | -838.58M | -795.12M |
| Treasury Stock & Other | 56.00K | 105.00K | 119.00K | -20.00K | 226.00K |
| Total Common Equity | 480.89M | 538.75M | 372.25M | 447.60M | 480.92M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 480.89M | 538.75M | 372.25M | 447.60M | 480.92M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 480.89M | 538.75M | 372.25M | 447.60M | 480.92M |
|
|
|||||